Dr. Kun-Po Li, BD Director of T-E Meds, an is set to captivate the audience at The BiG ADC/XDC Conference on March 8-9, 2024, hosted in the vibrant city of Shanghai, China.
Embark on a fascinating exploration of the dynamic Antibody-Drug Conjugates (ADCs) landscape. Dr. Li will unravel the innovations behind our cutting-edge ADC platform, highlighting the distinctive “Multi-Arm Linkers.” This proprietary technology not only optimizes Drug-to-Antibody Ratios (DARs) but also facilitates the groundbreaking realm of dual-payload designs.
It’s a great opportunity to connect, exchange insights, foster collaborations, and collectively shape the future of ADCs. Shanghai awaits!
